Anna fishbein, MD

Sanofi
Glenview, IL, United States

physician scientist

Presentation(s):

• 0443: The Potential of an Oral TNFα Inhibitor with TNFR1 Specificity: Results of a Phase 1b Proof-of-mechanism Trial in Psoriasis

  Sunday, November 12, 2023
  9:00 AM – 11:00 AM PT

  Disclosure information not submitted.